home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Immunotherapy Of Human Cancer: Lessons From Mice [A Commentary]

  October, 26 2000 1:51
your information resource in human molecular genetics
Immunotherapy of human cancer: lessons from mice [A Commentary]

It has always been difficult to translate mouse models into clinical therapies. The study of cancer immunity in mice has resulted in the identification of heat shock proteins as chaperones of antigenic peptides, and their possible use in the immunotherapy of human cancer. However, these immunotherapies also have to contend with an approval process designed for testing drugs. In a Commentary in the November 2000 issue of Nature Immunology (Vol. 1, No. 5), Pramod Srivastava of Farmington, Connecticut, USA, reflects on the challenges posed by immunotherapy, especially those unique to heat shock proteins, and suggests that different endpoints and objectives may need to be considered when evaluating the efficacy of newer approaches.


Pramod K. Srivastava
Center for Immunotherapy of Cancer and Infectious Diseases (MC1601)
University of Connecticut School of Medicine
Farmington, CT 06030-1601

E-mail: srivastava@nso2.uchc.edu

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.